AzTrials
AzTrials

Menstrual PainSTAMPNCT07130292

Abdominal Muscle Strengthening for Menstrual Symptoms in Primary Dysmenorrhea

A study testing Abdominal Muscle Strengthening Exercises with Stabilizer Pressure Biofeedback in people with Menstrual Pain and Menstrual Disorders, run by Bulent Ecevit University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled trial aims to investigate the effects of abdominal muscle strengthening exercises using a stabilizer pressure biofeedback device on menstrual symptoms and abdominal muscle strength in young women with primary dysmenorrhea. Read more about this study

Who is it for?
Ages 18 to 25 years, women only
What is being tested?
Abdominal Muscle Strengthening Exercises with Stabilizer Pressure Biofeedback
Could I receive a placebo?
No, everyone receives an active treatment
How many people
58 participants
Where
No sites listed yet
Study dates
13 Aug 2025to 25 Sep 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Female participants aged 18-25 years
  • Regular menstrual cycles
  • Diagnosed with primary dysmenorrhea (no secondary dysmenorrhea or other gynecological disorders)
  • Menstrual pain intensity ≥ 4 on the Visual Analog Scale (VAS) during the menstrual cycle
  • Willingness to participate and ability to provide informed consent

Who cannot join

  • Diagnosis of secondary dysmenorrhea or other gynecological disorders (e.g., endometriosis, adenomyosis, uterine fibroids)
  • Current pregnancy or breastfeeding
  • History of abdominal or pelvic surgery in the past 6 months
  • Current use of hormonal therapy or analgesic medication that could affect menstrual pain assessment
  • Participation in regular abdominal or core strengthening exercise programs within the last 3 months
  • Any musculoskeletal, neurological, or systemic condition that could interfere with exercise performance or study participation

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Effects of Abdominal Muscle Strengthening Using Stabilizer Pressure Biofeedback on Menstrual Symptoms and Abdominal Muscle Strength in Young Women With Primary Dysmenorrhea: A Randomized Controlled Trial

This randomized controlled trial aims to investigate the effects of abdominal muscle strengthening exercises using a stabilizer pressure biofeedback device on menstrual symptoms and abdominal muscle strength in young women with primary dysmenorrhea. Primary dysmenorrhea, characterized by painful menstrual cramps without underlying pelvic pathology, is common among women of reproductive age and can negatively affect quality of life.

In this study, 58 female participants aged 18-25 with regular menstrual cycles and a Visual Analog Scale (VAS) pain score of ≥4 will be randomly assigned to either an intervention group or a control group. The intervention group will perform abdominal strengthening and stretching exercises guided by a stabilizer pressure biofeedback device, three times per week for 6 weeks (excluding menstruation weeks).

The main outcomes include menstrual symptom severity (assessed by the Menstrual Symptom Scale), pain intensity (VAS), and abdominal muscle strength (measured using the stabilizer pressure biofeedback device). The results will help determine whether targeted abdominal muscle training can reduce menstrual symptoms and improve muscle strength in women with primary dysmenorrhea.

Read the detailed description

Primary dysmenorrhea (PD) is one of the most common gynecological problems in women of reproductive age, characterized by spasmodic cramps in the lower abdomen before or during menstruation, without pelvic pathology. The underlying pathophysiology involves increased release of prostaglandin F2α during menstruation, leading to stronger uterine contractions, reduced blood flow, hypoxia, and pain. PD often begins soon after menarche and may be accompanied by nausea, vomiting, diarrhea, fatigue, and sleep disturbances.

Conventional treatment approaches include pharmacological methods such as nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal contraceptives. However, these treatments may have side effects and limited patient compliance. Non-pharmacological interventions, especially exercise programs, have shown potential in reducing menstrual pain by increasing endorphin release, relaxing uterine muscles, and improving regional blood flow. Strengthening abdominal and core muscles can improve pelvic stability and potentially reduce dysmenorrhea symptoms.

The stabilizer pressure biofeedback unit is a simple, non-invasive device that provides visual feedback during muscle activation, helping to target deep stabilizing muscles such as the transversus abdominis. By enhancing activation capacity, it may improve abdominal muscle strength and reduce menstrual symptoms.

Study Design:

This is a randomized, controlled, single-blind trial. Fifty-eight eligible women aged 18-25 with regular menstrual cycles, a VAS score ≥4, and no diagnosis of secondary dysmenorrhea or other gynecological disorders will be enrolled. Participants will be allocated to the intervention or control group using permuted block randomization. Assessments will be conducted three times: at baseline (first day of the menstrual cycle), mid-intervention (week 3-4), and post-intervention (week 8).

Intervention:

The intervention group will perform a structured exercise program targeting the lumbar and abdominal muscles, supervised three times per week for 6 weeks (excluding menstruation weeks). Exercises will include stretching, mobility, and strengthening activities, with abdominal muscle training guided by a stabilizer pressure biofeedback device. The control group will not receive this intervention during the study period.

Outcome Measures:

Primary outcomes: Menstrual symptom severity (Menstrual Symptom Scale), pain intensity (VAS).

Secondary outcome: Abdominal muscle strength (stabilizer pressure biofeedback).

Significance:

This study will provide evidence on whether non-pharmacological abdominal muscle strengthening using stabilizer pressure biofeedback can reduce menstrual symptoms and improve muscle strength in young women with primary dysmenorrhea. The findings may guide future exercise-based interventions for menstrual pain management.

Being tested
Abdominal Muscle Strengthening Exercises with Stabilizer Pressure Biofeedback
Keywords
Primary Dysmenorrhea, Abdominal Muscle Strengthening, Stabilizer Pressure Biofeedback
Medical subject headings
Dysmenorrhea, Menstruation Disturbances

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Abdominal Muscle Strengthening Exercises with Stabilizer Pressure BiofeedbackBehavioural

    A supervised exercise program designed to strengthen abdominal and lumbar muscles, incorporating the use of a stabilizer pressure biofeedback device to enhance activation of deep stabilizing muscles such as the transversus abdominis. The program is delivered three times per week for 6 weeks (excluding menstruation weeks) and includes mobility, stretching, and strengthening exercises.

Study groups in NCT07130292
Study groupRoleWhat they receive
Intervention - Abdominal Muscle Strengthening with Stabilizer Pressure BiofeedbackExperimentalParticipants perform a structured exercise program targeting lumbar and abdominal muscles, guided by a stabilizer pressure biofeedback device. Sessions are supervised three times per week for 6 weeks (excluding menstruation weeks) and include mobility, stretching, and strengthening exercises to improve abdominal muscle activation and core stability.
Receives: Behavioral: Abdominal Muscle Strengthening Exercises with Stabilizer Pressure Biofeedback
Control - No Abdominal Muscle Strengthening InterventionNo interventionParticipants receive no abdominal muscle strengthening program during the study period. They continue their usual daily activities without any supervised exercise intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Menstrual Symptom Severity

    Change in menstrual symptom severity as assessed by the Menstrual Symptom Scale (MSS). The MSS consists of 22 items scored on a 5-point Likert scale, with higher scores indicating more severe symptoms.

    Measured: Change from Baseline (Week 0) to Post-intervention (Week 8)

  2. Pain Intensity

    Visual Analog Scale 0-10 cm (0 = no pain, 10 = worst pain). Outcome is mean change from baseline to Week 8.

    Measured: Change from Baseline (Week 0) to Post-intervention (Week 8)

  3. Abdominal Muscle Activation/Strength (Pressure Biofeedback)

    Abdominal muscle activation measured with a Stabilizer Pressure Biofeedback Unit (mmHg). Lower pressure during correct drawing-in reflects better transversus abdominis activation. Outcome is change from baseline to Week 8

    Measured: Change from Baseline (Week 0) to Post-intervention (Week 8)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2025
  2. Study start13 Aug 2025 (estimated)
  3. Primary completion23 Sep 2025 (estimated)
  4. Study completion25 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned into two parallel groups: an intervention group receiving abdominal muscle strengthening and stretching exercises guided by a stabilizer pressure biofeedback device, and a control group receiving no such intervention during the study period. Both groups will be evaluated at baseline, mid-intervention, and post-intervention over an 8-week period.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
58 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07130292
Sponsor's protocol ID
ZBEU-SPB-PD-2025-01
Acronym
STAMP
Status last verified
Aug 2025
First submitted
12 Aug 2025
Last updated
19 Aug 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared because the study protocol and informed consent do not include provisions for public data sharing, and data protection regulations restrict the release of personally identifiable health information.

Questions about this trial

What is this clinical trial studying?

A study testing Abdominal Muscle Strengthening Exercises with Stabilizer Pressure Biofeedback in people with Menstrual Pain and Menstrual Disorders, run by Bulent Ecevit University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 19 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sanem ŞENER (+90 553-591-83-96, sanemsener@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Menstrual Symptom Severity (time frame: Change from Baseline (Week 0) to Post-intervention (Week 8)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in